Diagnostic Approach and Management of Male Dysuria

Initial Evaluation and Diagnostic Testing

The American Urological Association recommends obtaining a detailed medical history focusing on symptom duration, severity, associated symptoms, sexual history, and medication use in men with dysuria 2
A focused physical examination including external genitalia examination and digital rectal examination should be performed to evaluate prostate size and tenderness in men with dysuria 2
Urinalysis should be conducted to detect infection, hematuria, or glycosuria in all men with dysuria 3, 2
The International Prostate Symptom Score (IPSS) should be utilized to quantify symptom frequency and severity in men with dysuria 1
Urine culture should be obtained to guide appropriate antibiotic therapy if infection is suspected in men with dysuria 2

Consider PSA testing in men with at least a 10-year life expectancy or when it may change management of voiding symptoms 3, 4
Post-void residual (PVR) volume should be measured to rule out significant urinary retention in men with dysuria 5
Uroflowmetry should be considered for men with LUTS suggesting abnormality of voiding/emptying 6, 7
Urine cytology may be considered in men with predominantly irritative symptoms, especially with smoking history or other risk factors for bladder cancer 4

Alpha-blockers should be initiated as first-line therapy for men with LUTS/BPH, as recommended by the American Urological Association 1, 2
Consider adding 5-alpha reductase inhibitors for men with prostate volume >30cc 1
Reassess patients 4-12 weeks after initiating treatment to evaluate response using IPSS 1
If symptoms do not improve or side effects are intolerable, consider changing medical management 1
Interstitial cystitis/bladder pain syndrome treatment should focus on pain management and symptom relief, as recommended by the American Urological Association 8
For urethral stricture or anatomical abnormalities, referral to urology for potential procedural intervention is recommended 2

Patients should be evaluated 4-12 weeks after initiating treatment to assess response, including the IPSS and may include PVR and uroflowmetry 1, 5
Patients with persistent symptoms despite appropriate treatment should undergo further evaluation and consideration of specialist referral 1, 2

Not assessing post-void residual in older men with dysuria may miss significant urinary retention 5, 2
Overlooking the possibility of prostate cancer in men with persistent dysuria and LUTS 3, 4